Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Hongo

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Urology Case Reports|January 31, 2023
Spontaneous ureterocele wall rupture by a ureteral stone: A case reportTaisuke Ezaki, Hiroshi Hongo
BMC Cancer|June 13, 2019
Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case reportTakeo Kosaka, Hiroshi Hongo, Mototsugu Oya
Urology Case Reports|March 10, 2016
Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate CancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 2, 2015
Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
Cancer Science|July 11, 2018
Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
BMC Cancer|July 24, 2019
Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case reportYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2021
Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screeningHiroshi Hongo, Takeo Kosaka, Yoko Suzuki, et al.
Molecular and Clinical Oncology|December 15, 2018
Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxelTakeo Kosaka, Hiroshi Hongo, Ryuichi Mizuno, et al.
IJU Case Reports|August 4, 2020
Clinically complete response to abiraterone acetate in a patient with metastatic castration-resistant prostate cancerYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Scientific Reports|April 17, 2021
Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancerKeitaro Watanabe, Takeo Kosaka, Hiroshi Hongo, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Urology Case Reports|January 31, 2023
Spontaneous ureterocele wall rupture by a ureteral stone: A case reportTaisuke Ezaki, Hiroshi Hongo
BMC Cancer|June 13, 2019
Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case reportTakeo Kosaka, Hiroshi Hongo, Mototsugu Oya
Urology Case Reports|March 10, 2016
Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate CancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 2, 2015
Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
Cancer Science|July 11, 2018
Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancerHiroshi Hongo, Takeo Kosaka, Mototsugu Oya
BMC Cancer|July 24, 2019
Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case reportYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2021
Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screeningHiroshi Hongo, Takeo Kosaka, Yoko Suzuki, et al.
Molecular and Clinical Oncology|December 15, 2018
Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxelTakeo Kosaka, Hiroshi Hongo, Ryuichi Mizuno, et al.
IJU Case Reports|August 4, 2020
Clinically complete response to abiraterone acetate in a patient with metastatic castration-resistant prostate cancerYoshinori Yanai, Takeo Kosaka, Hiroshi Hongo, et al.
Scientific Reports|April 17, 2021
Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancerKeitaro Watanabe, Takeo Kosaka, Hiroshi Hongo, et al.
Pageof 7